Poster PDFs, podium talks, and conference presentations, including formally published or indexed conference abstracts.
Machine Learning to Differentiate Congestive Heart Failure Onset Among High-Risk Patients Identified by the Framingham Risk Score
Sicilia M., van der Pluijm W.
ISPOR 2026 · May 17–20
Read →
Declining Baseline HbA1c at GLP-1 Receptor Agonist Initiation in U.S. Adults with Type 2 Diabetes, 2015–2024
Panthari A., Sicilia M., van der Pluijm W.
ISPOR 2026 · May 17–20
Read →
Real-World Concordance With the Framingham Stroke Risk Model in Atrial Fibrillation and Identification of Additional Significant Features
Sicilia M., van der Pluijm W.
ISPOR 2026 · May 17–20
Read →
Association Between GLP-1 Receptor Agonist Initiation and Alcohol Use Disorder and Alcohol-Related Medical Conditions in a U.S. Administrative Claims Database
van der Pluijm W., Neilson D., Anand A.
ISPOR 2026 · May 17–20
Read →
Observed Cardiovascular Disease Prevalence Among Obese and Type 2 Diabetes Patients With and Without GLP-1 Treatment
Panthari A., Sicilia M., van der Pluijm W.
ISPOR 2026 · May 17–20
Read →
Trends in Preeclampsia Prevalence and Comorbidity Burden Among Pregnant Women Using U.S. Administrative Claims Data
van der Pluijm W., Sicilia M., Anand A.
ISPOR 2026 · May 17–20
Read →
Observed Real-World Diagnosis and Specialist Visit Patterns in Newly Diagnosed and Relapsing MS Patients
Sicilia M.
ISPOR 2026 · May 17–20
Read →
Genomic and Ancestry-Associated Determinants of Survival in Gynecologic Cancers
Chambers L., Ramu A., Aushev V., Rojahn S., Antonopoulos A., Scalise C., Salmasi F., Liu M., ElNaggar A., Arend A.
AACR 2026 · Apr 17–22
Read →
Genetic Characterization and Clinical Manifestations in Adults with Hypophosphatasia in the United States
Lyons G., Vlasnik J., Jastrab A., Abramson A., Sullivan B., Anand A., Sicilia M., Panthari A., Peroutka C.
ACMG 2026 · Mar 10–14
Read →
Understanding Patient Experience in the Management and Prioritization of MASH and Comorbidities: Results from a Claims Analysis and Qualitative Patient Interviews
Hadac J., Anand A., Jones J., Neilson D., van der Pluijm W., Wu A., Fok L.
WCIRDC 2025 · Dec 3–6
Read →
Effect of Selumetinib Treatment on Long-Term Pain Medication Utilization in Pediatric Patients: A Retrospective Study of a US Claims Database
Meade J., Lyons G., Anand A., Sicilia M., van der Pluijm W., Bowling A., Guikema B., Dettling T.
SNO 2025 · Nov 19–23
Read →
Effect of Selumetinib Treatment on Long-Term Pain Medication Utilization in Pediatric Patients: A Retrospective Study of a US Claims Database
Meade J., Lyons G., Anand A., Sicilia M., van der Pluijm W., Bowling A., Guikema B., Dettling T.
Neuro-Oncology · 2025 · Abstract QOL-27
Read →
Corticosteroid Toxicity and Related Healthcare Resource Utilization in Patients with Myasthenia Gravis in the USA
Ragole T., Blackowicz M., Weiskopf E., Anand A., Sicilia M.
Poster Presentation · AANEM 2025 · Oct 29–Nov 1
Read →
Estimating Genital Herpes Prevalence and Treatment Patterns Among US Healthcare-Engaged Individuals: Insights From Claims Data
Lian L., Johnston C., Seo M., Kitrinos K., Gaggar A., Deer J.
STI & HIV 2025 World Congress · Jul 2025
Read →
Concomitant Usage of Contraindicated Medications in Patients with Atrial Fibrillation: A Comparison of RWD Sources in the US
Sicilia M., van der Pluijm W.
ISPOR 2025 · May 13–16
Read →
Trends in GLP-1 Utilization for Diabetes and Obesity in the US: A Retrospective Analysis (2017–2023)
van der Pluijm W., Sicilia M.
ISPOR 2025 · May 13–16
Read →
Baseline BMI and HbA1c Trends in US Diabetic Patients Initiating GLP-1 Therapy: A Retrospective Cohort Study
van der Pluijm W., Sicilia M.
ISPOR 2025 · May 13–16
Read →
Early Breast Cancer in the US and Germany: A Comparison of Real-World Screening and Treatment
Simeone J., Menou S., van der Pluijm W., Sicilia M.
ISPOR 2025 · May 13–16
Read →
Estimating Genital Herpes Prevalence and Treatment Patterns Among US Healthcare-Engaged Individuals: Insights from Claims Data
Lian L., Johnston C., Seo M., Kitrinos K., Gaggar A., Deer J.
Poster Presentation · ESCMID 2025 · Apr 11–15
Read →
Longitudinal Associations of Corticosteroid Dose with Corticosteroid Toxicity in Patients with Myasthenia Gravis in the USA
Ragole T., Blackowicz M., Weiskopf E., Anand A., Sicilia M., Wolfe G.
MDA 2025 · Mar 16–19
Read →
Using Longitudinal Claims Data to More Accurately Predict Response Uptake Curves in Rare & Ultra Rare Disease
Rosenblatt J., Rosenberg R., Anand A.
Theater Presentation · PMSA 2024 · May 5–8
Read →
Emergency Room Utilization Among Multiple Sclerosis Patients Treated with Disease-Modifying Therapy in a Real-World Hybrid Claims Database
Kuranz S.
ISPOR 2024 · May 5–8
Read →
Patterns of Treatment Initiation by Sarcoidosis Type in a Real-World Hybrid Claims Database
Kuranz S., Westall T.
ISPOR 2024 · May 5–8
Read →
Progression to ESRD Among White, Black and Hispanic Diabetic Kidney Disease Patients Treated From Multiple Linked Claims Databases
Kuranz S.
ICPE 2023 · Aug 23–27
Read →
Association of Cannabis Use with Real-World Time to Treatment Discontinuation in Advanced Cancer Patients Initiating Immune Checkpoint Inhibition
Zylla D., Knowlton G., Gilmore G., Pawloski P.A., Salz T., Kulkarni A.A., Cowger J., Kuranz S.
ASCO 2023 · Jun 2–6
Read →
Real World Evidence on the Use of ECMO in Hospitalized COVID-19 Patients: Results From a Linked Closed and Open Claims Database in the US
Kuranz S., Neilson D.
ISPOR 2023 · May 7–10
Read →
Adherence and Persistence with SGLT-2 Inhibitors Among White and Black Diabetic Kidney Disease Patients: Real-World Evidence From a Large US Claims Database
Kuranz S.
ISPOR 2023 · May 7–10
Read →
Estimating the Cost of End-of-Life Care Among US Adults: Real-World Evidence Using a Case-Crossover Study Design
Kuranz S., Neilson D., van der Pluijm W.
ISPOR 2023 · May 7–10
Read →
Real-World Evidence on the Association Between the Use of Cannabis and Healthcare Resource Utilization Among Patients With Chronic Post-Traumatic Stress Disorder
Kuranz S., Anand A., van der Pluijm W.
ISPOR 2023 · May 7–10
Read →
The Cost of Care Among Infantile and Child Spinal Muscular Atrophy Patients: RWE From a Large Claims Database
Kuranz S., van der Pluijm W.
ISPOR Europe 2022 · Nov 6–9
Read →
Epidemiological Estimate of the Prevalence of the Coded Nonalcoholic Steatohepatitis (NASH) Population in the US Using an Administrative Claims Dataset
Fishman J., Hubbert A., van der Pluijm W., Zhang C., Sun An Y.
ISPOR Europe 2022 · Nov 6–9
Read →
